Brief: Lexaria Bioscience Enters Change Order To Terms Of Its Project Agreement With Novotech
12/06/2025 22:00
June 12 (Reuters) - Lexaria Bioscience Corp LEXX.O: LEXARIA BIOSCIENCE CORP - ENTERS CHANGE ORDER TO TERMS OF ITS PROJECT AGREEMENT WITH NOVOTECH - SEC FILING LEXARIA BIOSCIENCE CORP - CHANGE ORDER ADDS 5TH STUDY ARM FOR DEHYDRATECH-TIRZEPATIDE CAPSULES IN ITS AUSTRALIAN CLINICAL STUDY- SEC FILING LEXARIA BIOSCIENCE CORP - CHANGE ORDER RESULTS IN ADDITIONAL COSTS OF AU$1.9 MILLION - SEC FILING Source text: [ID:n0001640334-25-001030] Further company coverage: LEXX.O (((( Reuters.briefs@thomsonreuters.com ;));))